GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
Clinical trial NCT05557578 · RECRUITING
Trial details
- NCT number
- NCT05557578
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-05
- Primary completion
- 2025-11-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.